Showing results (1741-1750 of 3,615) with videos related to
Sort By:
Pageof 362
Journal of Viral Hepatitis|February 22, 2023
The infection rates of HBV and HCV decreased significantly in Zhejiang Province, China: A comparative study based on the data of two sero-epidemiological surveys in 1992 and 2020Yang Zhou, Botao Zhao, Wen Shi, et al.Journal of Viral Hepatitis|March 9, 2023
Comparison of acknowledged hepatocellular carcinoma risk scores in high-risk hepatitis C patients with sustained virological responseLixia Qiu, Shanshan Xu, Yundong Qiu, et al.Journal of Viral Hepatitis|August 2, 2016
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative studyH Nishikawa, H Enomoto, Y Iwata, et al.Journal of Viral Hepatitis|July 3, 2015
Clinical impact of treatment timing for chronic hepatitis C infection: a decision modelM T Pho, D M Jensen, D O Meltzer, et al.Journal of Viral Hepatitis|August 26, 2021
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis BHye Won Lee, Young Youn Cho, Hyein Lee, et al.Journal of Viral Hepatitis|August 27, 2021
Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/pibrentasvir in Phase 2 and 3 clinical trialsEdward Gane, Victor de Ledinghen, Douglas E Dylla, et al.Journal of Viral Hepatitis|August 27, 2021
Long-term benefits of interferon-α therapy in children with HBeAg-positive immune-active chronic hepatitis BLimin Wang, Jinfang Zhao, Jiaye Liu, et al.Journal of Viral Hepatitis|August 23, 2022
Changes in alcohol use during hepatitis C treatment in persons who inject drugsMadhuri Martin, Prerana J Roth, Jiajing Niu, et al.Journal of Viral Hepatitis|February 6, 2023
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysisIra M Jacobson, Stefan Bourgeois, Phillipe Mathurin, et al.Journal of Viral Hepatitis|December 4, 2025
Immune Checkpoints Determine the NK/NKT and T Cell Immunity in Chronic Hepatitis BXiaoyan Li, Chunhong Liao, Yurong Gu, et al.Pageof 362